Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.97 USD | +1.03% | +5.91% | -1.01% |
05-14 | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
05-13 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.01% | 34.23M | |
+22.91% | 87.14B | |
-23.75% | 75.59B | |
+1.76% | 26.78B | |
+4.38% | 17.89B | |
-14.20% | 16.44B | |
+2.34% | 15.68B | |
+72.91% | 13.3B | |
+76.91% | 13.06B | |
+3.32% | 12.54B |
- Stock Market
- Equities
- XGN Stock
- News Exagen Inc.
- Earnings Flash (XGN) EXAGEN Reports Q1 Revenue $14.4M, vs. Street Est of $13.1M